Targeted Cancer Therapy Employing the Combination of Artificial Intelligence and Nanotechnology
Keywords:
Cancer therapy, biomarker, nanoparticles (NPs), drug delivery, artificial intelligence (AI)Abstract
Cancer is a deadly illness that accounts for about 10 million deaths annually around the globe. Different molecular fingerprints in the human body mean different prognostic information for cancer patients. However, variation in gene expression emerges as a result of different types of cancer and modifications in the cancers, complicating both diagnosis and treatment. Precision medicine in cancer therapy relies heavily on targeted drug delivery, which helps provide medicines to patients by strategically raising local concentrations of the substance there. Nanoparticle (NPs) mediated administering medications and the inclusion of Artificial Intelligence (AI) is helpful techniques for enhancing customized delivery systems for drugs with biomarker identification. The accumulation of NPs in localized cancer facilitates biomarker detection and allows for precise medication delivery planning. Using NPs for cancer targeting in conjunction with AI may lead to the development of cutting-edge systems for better categorizing and understanding the many forms of the illness. The evaluation of pharmacological effectiveness, the prediction of potential NPs interactions of the targeted medicine, and the discovery of biomarkers are all areas where cutting-edge AI systems may aid. Despite the obvious benefits of combining NPs with AI for targeted medication delivery, this topic has received surprisingly little attention in the literature, with most suggested studies focused instead on the intersection of AI and drug development. The primary objective of this research was to emphasize the impact of NPs' recent advances in drug administration on customized cancer treatment plans. Additionally, the paper emphasizes how combining AI and NPs might assist overcome some of the current difficulties in medication administration via a collaborative investigation.
Downloads
References
Wilson B, Km G. Artificial intelligence and related technologies enabled nanomedicine for advanced cancer treatment. Nanomedicine. 2020 Feb;15(05):433-5.
Adir O, Poley M, Chen G, Froim S, Krinsky N, Shklover J, Shainsky‐Roitman J, Lammers T, Schroeder A. Integrating artificial intelligence and nanotechnology for precision cancer medicine. Advanced Materials. 2020 Apr;32(13):1901989.
Haleem A, Javaid M, Singh RP, Rab S, Suman R. Applications of Nanotechnology in Medical field. Global Health Journal. 2023 Feb 25.
Liu D, Dai X, Ye L, Wang H, Qian H, Cheng H, Wang X. Nanotechnology meets glioblastoma multiforme: Emerging therapeutic strategies. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology. 2023 Jan;15(1):e1838.
Chen M, Zhou Y, Lang J, Li L, Zhang Y. Triboelectric nanogenerator and artificial intelligence to promote precision medicine for cancer. Nano Energy. 2022 Feb 1; 92:106783.
Brar B, Ranjan K, Palria A, Kumar R, Ghosh M, Sihag S, Minakshi P. Nanotechnology in colorectal cancer for precision diagnosis and therapy. Frontiers in Nanotechnology. 2021 Sep 16; 3:699266.
Lin Z, Chou WC, Cheng YH, He C, Monteiro-Riviere NA, Riviere JE. Predicting nanoparticle delivery to tumors using machine learning and artificial intelligence approaches. International Journal of Nanomedicine. 2022 Jan 1:1365-79.
Pan S, Zhang Y, Natalia A, Lim CZ, Ho NR, Chowbay B, Loh TP, Tam JK, Shao H. Extracellular vesicle drug occupancy enables real-time monitoring of targeted cancer therapy. Nature nanotechnology. 2021 Jun; 16(6):734-42.
Gadag S, Sinha S, Nayak Y, Garg S, Nayak UY. Combination therapy and nanoparticulate systems: Smart approaches for the effective treatment of breast cancer. Pharmaceutics. 2020 Jun 8; 12(6):524.
Zhang Y. Development of NPs and their application in cancer treatment. In Proceedings of the 2nd International Symposium on Artificial Intelligence for Medicine Sciences 2021 Oct 29 (pp. 236-240).
Hu D, Pan M, Yu Y, Sun A, Shi K, Qu Y, Qian Z. Application of nanotechnology for enhancing photodynamic therapy via ameliorating, neglecting, or exploiting tumor hypoxia. View. 2020 Mar;1(1):e6.
Moore JA, Chow JC. Recent progress and applications of gold nanotechnology in medical biophysics using artificial intelligence and mathematical modeling. Nano Express. 2021 Apr 7;2(2):022001.
Tan P, Chen X, Zhang H, Wei Q, Luo K. Artificial Intelligence Aids in Development of Nanomedicines for Cancer Management. InSeminars in Cancer Biology 2023 Jan 20. Academic Press.
Kemp JA, Kwon YJ. Cancer nanotechnology: current status and perspectives. Nano convergence. 2021 Nov 2;8(1):34.
Freitas SC, Sanderson D, Caspani S, Magalhães R, Cortés-Llanos B, Granja A, Reis S, Belo JH, Azevedo J, Gómez-Gaviro MV, Sousa CT. New Frontiers in Colorectal Cancer Treatment Combining Nanotechnology with Photo-and Radiotherapy. Cancers. 2023 Jan; 15(2):383.
Alafeef M, Srivastava I, Pan D. Machine learning for precision breast cancer diagnosis and prediction of the nanoparticle cellular internalization. ACS sensors. 2020 May 29;5(6):1689-98.
Zhang P, Meng J, Li Y, Yang C, Hou Y, Tang W, McHugh KJ, Jing L. Nanotechnology-enhanced immunotherapy for metastatic cancer. The Innovation. 2021 Nov 28;2(4):100174.
Chen M, Zhou Y, Lang J, Li L, Zhang Y. Triboelectric nanogenerator and artificial intelligence to promote precision medicine for cancer. Nano Energy. 2022 Feb 1; 92:106783.
Tajunisa M, Sadath L, Nair RS. Nanotechnology and Artificial Intelligence for Precision Medicine in Oncology. InArtificial Intelligence 2021 Jul 28 (pp. 103-122). CRC Press.
Javed Iqbal M, Quispe C, Javed Z, Sadia H, Qadri QR, Raza S, Salehi B, Cruz-Martins N, Abdulwanis Mohamed Z, Sani Jaafaru M, Abdull Razis AF. Nanotechnology-based strategies for berberine delivery system in cancer treatment: pulling strings to keep berberine in power. Frontiers in molecular biosciences. 2021 Jan 15; 7:624494.
Murar M, Albertazzi L, Pujals S. Advanced optical imaging-guided nano theranostics towards personalized cancer drug delivery. Nanomaterials. 2022 Jan 26; 12(3):399.
Jayanthi, R,. & Sunethra, B. (2022). Review on Quantum Computers in Machine Learning. Technoarete Transactions on Advances in Computer Applications (TTACA), 1 (1), 20-24.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJISAE open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
